Literature DB >> 15947979

Acute renal failure after overdose of colloidal bismuth subcitrate.

Nurcan Cengiz1, Yasemin Uslu, Faysal Gök, Ali Anarat.   

Abstract

Bismuth salts are widely used to treat peptic ulcers. Acute toxicity with colloidal bismuth subcitrate overdose causes nephrotoxicity. There have been numerous reports of encephalopathy after long-term consumption of bismuth salts, but only a few cases of nephrotoxicity (adult and pediatric) have been documented to date. This report presents a case of acute renal failure due to colloidal bismuth subcitrate overdose in adolescent. A 16-year-old girl presented with complaints of nausea, vomiting, and facial paresthesia. Ten days earlier she had tried to commit suicide by taking 60 tablets of De-nol (colloidal bismuth subcitrate 18 g). The physical examination findings on admission indicated minimal fluid overload but no signs of encephalopathy. Laboratory tests on admission showed blood urea nitrogen 102 mg/dl, serum creatinine 19.9 mg/dl, and serum bismuth level 495 microg/l. The patient was started on appropriate fluid therapy and penicillamine as a chelating agent and then began hemodialysis on alternate days. The patient's renal function gradually returned to normal over 9 weeks and by 64 days after the overdose her serum bismuth level had fallen to almost half the level detected 2 days after admission. The patient made a complete recovery. The case demonstrates that acute renal failure can develop as a manifestation of acute toxicity from colloidal bismuth ingestion, and that the prognosis may be favorable if the patient receives appropriate supportive treatment and dialysis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15947979     DOI: 10.1007/s00467-005-1993-7

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  19 in total

1.  Bismuth absorption and myoclonic encephalopathy during bismuth subsalicylate therapy.

Authors:  P C Mendelowitz; R S Hoffman; S Weber
Journal:  Ann Intern Med       Date:  1990-01-15       Impact factor: 25.391

Review 2.  Bismuth therapy in gastrointestinal diseases.

Authors:  S L Gorbach
Journal:  Gastroenterology       Date:  1990-09       Impact factor: 22.682

3.  Bismuth overdosing-induced reversible nephropathy in rats.

Authors:  B T Leussink; A Slikkerveer; M R Engelbrecht; G B van der Voet; E J Nouwen; E de Heer; M E de Broe; F A de Wolff; J A Bruijn
Journal:  Arch Toxicol       Date:  2001-02       Impact factor: 5.153

4.  Reversible toxicity in poisoning with colloidal bismuth subcitrate.

Authors:  M Hudson; N A Mowat
Journal:  BMJ       Date:  1989-07-15

5.  Significant elimination of bismuth by haemodialysis with a new heavy-metal chelating agent.

Authors:  P E Stevens; D F Moore; I M House; G N Volans; D J Rainford
Journal:  Nephrol Dial Transplant       Date:  1995       Impact factor: 5.992

Review 6.  Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.

Authors:  A J Wagstaff; P Benfield; J P Monk
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

Review 7.  Reversible nephrotoxicity after overdose of colloidal bismuth subcitrate.

Authors:  I Işlek; S Uysal; F Gök; R Dündaröz; S Küçüködük
Journal:  Pediatr Nephrol       Date:  2001-06       Impact factor: 3.714

8.  Pathways of proximal tubular cell death in bismuth nephrotoxicity.

Authors:  Berend T Leussink; J Fred Nagelkerke; Bob van de Water; Anja Slikkerveer; Gijsbert B van der Voet; Anu Srinivasan; Jan A Bruijn; Frederik A de Wolff; Emile de Heer
Journal:  Toxicol Appl Pharmacol       Date:  2002-04-15       Impact factor: 4.219

9.  Bismuth induced encephalopathy caused by tri potassium dicitrato bismuthate in a patient with chronic renal failure.

Authors:  R J Playford; C H Matthews; M J Campbell; H T Delves; K K Hla; H J Hodgson; J Calam
Journal:  Gut       Date:  1990-03       Impact factor: 23.059

Review 10.  Pharmacokinetics and toxicity of bismuth compounds.

Authors:  A Slikkerveer; F A de Wolff
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Sep-Oct
View more
  3 in total

1.  Comparison of three different regimens against Helicobacter pylori as a first-line treatment: A randomized clinical trial.

Authors:  Ayse Kefeli; Sebahat Basyigit; Abdullah Ozgur Yeniova; Tarık Tayfur Kefeli; Muzaffer Aslan; Ozlem Tanas
Journal:  Bosn J Basic Med Sci       Date:  2016-01-01       Impact factor: 3.363

Review 2.  Non-drug-induced nephrotoxicity.

Authors:  Justine Bacchetta; Laurence Dubourg; Laurent Juillard; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2009-04-28       Impact factor: 3.714

3.  A case of bismuth intoxication with irreversible renal damage.

Authors:  Abdulsamet Erden; Samet Karahan; Kadir Bulut; Mustafa Basak; Tuncay Aslan; Ali Cetinkaya; Hatice Karagoz; Deniz Avci
Journal:  Int J Nephrol Renovasc Dis       Date:  2013-11-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.